TAK-233
TAK-233/CPH-003
Phase 1 small_molecule completed
Quick answer
TAK-233 for Clinical Pharmacology is a Phase 1 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Clinical Pharmacology
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed